Together, we have highlighted dysregulated splicing of SFPQ in ALS, the translation potential of a previously identified mRNA isoform, and present this as a potential mechanism driving the nuclear loss and cytoplasmic gain of SFPQ protein in this disease (Fig. 7). The gene discussed is SFPQ; the disease is amyotrophic lateral sclerosis.